Robert Thompson Bio

Bob joined Pacific Growth Investors (PGI) in 2016 after working closely with the firm’s principals as CEO and a director of their funds’ portfolio companies. In his role as Operating Partner, Bob applies over twenty five years of C-level experience at public and private companies to provide valuable operating and financial guidance to PGI portfolio companies as a board member and advisor. He also participates in the investment evaluation, due diligence and portfolio monitoring processes. PGI Managing Partner Mark Sampson and Bob initiated their relationship in 2003 when Bob was CEO and a director of eScreen, one of Vintage Capital Partners’ (VCP’s) earliest investments. Under Bob’s leadership during VCP’s investment period, eScreen achieved tremendous organic growth and completed domestic and cross-border strategic acquisitions. VCP realized its investment in eScreen through its successful sale to a public company in 2012. Bob currently is CEO of Emerge Diagnostics, a medical diagnostics technology company. He approached PGI in 2016 to discuss management’s growth objectives and the company’s capital needs, resulting in PGI’s successful investment in Emerge. Therafter, Bob joined the board of VCP portfolio company Sandel Avionics in 2016 to provide strategic guidance to the growing company. Bob began his career in consulting and has held significant management positions at both public and private companies, including COO and CFO of LabOne. He earned his M.B.A. from Harvard Business School and his B.S. from the University of Pennsylvania.